759646448 | PUO | 39691196 | | 4134467 | 2/12/2002 12:00:00 AM | noncardiac chest pain , possible GERD | | DIS | Admission Date: 1/18/2002 Report Status:
Discharge Date: 10/10/2002
****** DISCHARGE ORDERS ******
KROCHMAL , STACI 757-96-96-7
Yonkers
Service: CAR
DISCHARGE PATIENT ON: 9/19/02 AT 05:00 PM
CONTINGENT UPON Not Applicable
WILL D/C ORDER BE USED AS THE D/C SUMMARY: YES
Attending: BERNAS , RUFUS CARLIE , M.D.
CODE STATUS:
Full code
DISPOSITION: Home
DISCHARGE MEDICATIONS:
VENTOLIN ( ALBUTEROL INHALER ) 2 PUFF INH QID
ALLOPURINOL 300 MG PO QD
Override Notice: Override added on 6/1/02 by FERRIERA , EVAN KRISTIE , M.D. , PH.D.
on order for THEOPHYLLINE ( SLOW RELEASE ) PO 200 MG TID
( ref # 89538329 )
POTENTIALLY SERIOUS INTERACTION: ALLOPURINOL &amp; THEOPHYLLINE
Reason for override: aware Previous override information:
Override added on 6/1/02 by FERRIERA , EVAN KRISTIE , M.D. , PH.D.
on order for THEOPHYLLINE ( SLOW RELEASE ) PO ( ref #
73129998 )
POTENTIALLY SERIOUS INTERACTION: ALLOPURINOL &amp; THEOPHYLLINE
Reason for override: home med
ECASA ( ASPIRIN ENTERIC COATED ) 325 MG PO QD
Override Notice: Override added on 6/1/02 by FERRIERA , EVAN KRISTIE , M.D. , PH.D.
on order for COUMADIN PO 5 MG QHS ( ref # 39548554 )
POTENTIALLY SERIOUS INTERACTION: ASPIRIN &amp; WARFARIN
Reason for override: aware Previous override information:
Override added on 6/1/02 by FERRIERA , EVAN KRISTIE , M.D. , PH.D.
POTENTIALLY SERIOUS INTERACTION: WARFARIN &amp; ASPIRIN
Reason for override: aware
CYCLOBENZAPRINE HCL 10 MG PO TID
DILTIAZEM SUSTAINED RELEASE 120 MG PO BID
Food/Drug Interaction Instruction
Avoid grapefruit unless MD instructs otherwise.
Override Notice: Override added on 6/1/02 by FERRIERA , EVAN KRISTIE , M.D. , PH.D.
on order for LASIX PO 40 MG QD ( ref # 90065416 )
POTENTIALLY SERIOUS INTERACTION: DILTIAZEM HCL &amp; FUROSEMIDE
Reason for override: aware Previous override information:
Override added on 6/1/02 by FERRIERA , EVAN KRISTIE , M.D. , PH.D.
on order for LASIX PO ( ref # 15973148 )
POTENTIALLY SERIOUS INTERACTION: DILTIAZEM HCL &amp; FUROSEMIDE
Reason for override: aware
Number of Doses Required ( approximate ): 8
FOLATE ( FOLIC ACID ) 1 MG PO QD
LASIX ( FUROSEMIDE ) 40 MG PO QD
Alert overridden: Override added on 6/1/02 by FERRIERA , EVAN KRISTIE , M.D. , PH.D.
POTENTIALLY SERIOUS INTERACTION: DILTIAZEM HCL &amp; FUROSEMIDE
Reason for override: aware Previous Alert overridden
Override added on 6/1/02 by FERRIERA , EVAN KRISTIE , M.D. , PH.D.
POTENTIALLY SERIOUS INTERACTION: DILTIAZEM HCL &amp; FUROSEMIDE
Reason for override: aware
LISINOPRIL 30 MG PO QD Starting Today ( 7/8 )
Override Notice: Override added on 6/1/02 by FERRIERA , EVAN KRISTIE , M.D. , PH.D.
on order for KCL SLOW RELEASE PO ( ref # 30962062 )
POTENTIALLY SERIOUS INTERACTION: LISINOPRIL &amp; POTASSIUM
CHLORIDE Reason for override: aware
NITROGLYCERIN 1/150 ( 0.4 MG ) 1 TAB SL Q5MIN X 3
PRN chest pain
THEOPHYLLINE ( SLOW RELEASE ) 200 MG PO TID
Food/Drug Interaction Instruction
Follow manufacturer's info re: take with food.
Give with meals
Override Notice: Override added on 6/1/02 by FERRIERA , EVAN KRISTIE , M.D. , PH.D.
on order for COUMADIN PO 5 MG QHS ( ref # 39548554 )
POTENTIALLY SERIOUS INTERACTION: THEOPHYLLINE &amp; WARFARIN
Reason for override: aware Previous override information:
Override added on 6/1/02 by FERRIERA , EVAN KRISTIE , M.D. , PH.D.
POTENTIALLY SERIOUS INTERACTION: WARFARIN &amp; THEOPHYLLINE
POTENTIALLY SERIOUS INTERACTION: ALLOPURINOL &amp; THEOPHYLLINE
Reason for override: aware Previous Alert overridden
Override added on 6/1/02 by FERRIERA , EVAN KRISTIE , M.D. , PH.D.
POTENTIALLY SERIOUS INTERACTION: WARFARIN &amp; THEOPHYLLINE
POTENTIALLY SERIOUS INTERACTION: ALLOPURINOL &amp; THEOPHYLLINE
Reason for override: home med
MVI THERAPEUTIC W/MINERALS ( THERAP VITS/MINERALS )
1 TAB PO QD
COUMADIN ( WARFARIN SODIUM ) 6.5 MG PO QHS
Starting Today ( 7/8 ) Food/Drug Interaction Instruction
No high Vitamin-K containing foods
Alert overridden: Override added on 6/1/02 by FERRIERA , EVAN KRISTIE , M.D. , PH.D.
POTENTIALLY SERIOUS INTERACTION: ASPIRIN &amp; WARFARIN
POTENTIALLY SERIOUS INTERACTION: THEOPHYLLINE &amp; WARFARIN
Reason for override: aware Previous Override Notice
Override added on 6/1/02 by FERRIERA , EVAN KRISTIE , M.D. , PH.D.
on order for THEOPHYLLINE ( SLOW RELEASE ) PO 200 MG TID
( ref # 89538329 )
POTENTIALLY SERIOUS INTERACTION: WARFARIN &amp; THEOPHYLLINE
Reason for override: aware Previous override information:
Override added on 6/1/02 by FERRIERA , EVAN KRISTIE , M.D. , PH.D.
on order for ECASA PO ( ref # 08796705 )
POTENTIALLY SERIOUS INTERACTION: WARFARIN &amp; ASPIRIN
Reason for override: aware Previous override information:
Override added on 6/1/02 by FERRIERA , EVAN KRISTIE , M.D. , PH.D.
on order for THEOPHYLLINE ( SLOW RELEASE ) PO ( ref #
73129998 )
POTENTIALLY SERIOUS INTERACTION: WARFARIN &amp; THEOPHYLLINE
Reason for override: home med
SEREVENT ( SALMETEROL ) 2 PUFF INH BID
KCL SLOW RELEASE 20 MEQ X 1 PO QD
As per PUO Potassium Chloride Policy:
each 20 mEq dose to be given with 4 oz of fluid
Alert overridden: Override added on 6/1/02 by FERRIERA , EVAN KRISTIE , M.D. , PH.D.
POTENTIALLY SERIOUS INTERACTION: LISINOPRIL &amp; POTASSIUM
CHLORIDE Reason for override: aware
FLOVENT ( FLUTICASONE PROPIONATE ) 880 MCG INH BID
NEXIUM ( ESOMEPRAZOLE ) 20 MG PO QD
RETURN TO WORK: Immediately
FOLLOW UP APPOINTMENT( S ):
Primary care physician 1-2 weeks ,
ALLERGY: Inderal ( beta-blockers ) , Quintrim
ADMIT DIAGNOSIS:
r/o MI
PRINCIPAL DISCHARGE DIAGNOSIS ;Responsible After Study for Causing Admission )
noncardiac chest pain , possible GERD
OTHER DIAGNOSIS;Conditions , Infections , Complications , affecting Treatment/Stay
ASTHMA HTN OSTEONECROSIS HIPS W/ REPL. GOUT DIVERTICULITIS LEUKOPLAKIA
cardiomyopathy ( ? etiology ) ? angina nevi excised from
legs EF 30-40% h/o EtOH abuse ( H/O alcohol
abuse ) h/o LV thrombus on coumadin AVN R elbow ( avascular necrosis
femoral head ) PVD ( peripheral vascular
disease ) h/o diverticulosis ( H/O diverticulosis ) h/o Trigeminy
OPERATIONS AND PROCEDURES:
None
OTHER TREATMENTS/PROCEDURES ( NOT IN O.R. )
None
BRIEF RESUME OF HOSPITAL COURSE:
53M with h/o CAD s/p MI 1995 , CMP EF 30% , h/o heavy EtOH use admitted
with 1 week of waxing and waning "crushing substernal CP" 2/10-8/10
lasting minutes to hours , radiating to back , without associated sx
other than some diaphoresis. Pain is NOT like previous angina. Not
associated with exertion. ROS otherwise negative. sleeps on 4 pillows
for chronic hip pain; no PND/LE edema. Admits to drinking 6
beers/day. PMH also sig for COPD/asthma , bilateral hip replacements , LV
thrombus on coumadin.
In ED 88 157/97 97% 2L NC exam sig for JVP 5 cm ,
RRR S1/S2 +S4 no murmurs. CTAB. Abd obese , no HSM. No LE edema , 2+
pulses EKG NSR 78 bpm LAD ?LAFB labs sig for CK 167 TnI 0.05 BNP 21.
WBC 5 HCt 43 Plt 88 ( has been low in past ). INR 1.8.
##CV
- completed r/o by enzymes/EKG x3
- cont home meds; apparently intolerant of beta-blockers in past. BP
control. No evidence of volume overload by hx or exam.
- dobutamine MIBI 4/6 max HR 127 , double product 23K. No chest pain
or EKG changes. Moderately dilated LV , severely dilated RV , LVEF 51%.
Fixed severe inferobasal defect with moderate inferior wall HK c/w
prior PDA infarct. No evidence of ischemia.
##Heme - thrombocytopenia but stable on repeat CBC , possibly secondary
to alcohol. Continued coumadin for LV thrombus
##GI
- antacids , PPI. Patient reports significant relief of GERD sx with
PPI. Will discharge with trial of PPI; possible that chest pain result
of GERD/dyspepsia.
##EtOH
- prophylactic lorazepam given , no evidence of withdrawal during
admission. Pt counseled on EtOH abstinence/reduction.
##pulm
- cont COPD meds
ADDITIONAL COMMENTS: 1 ) Call your doctor , return to ED or call 911 for crushing chest pain
that does not respond to 3 sublingual nitroglycerin tablets and lasts
more than 20 minutes.
DISCHARGE CONDITION: Stable
TO DO/PLAN:
recheck your coumadin level as instructed
No dictated summary
ENTERED BY: FRANKENBERRY , ANDREAS , M.D. ( TP16 ) 9/19/02 @ 06
****** END OF DISCHARGE ORDERS ******